This kit uses RT-PCR for in vitro detection of coronavirus 229E, OC43, NL63, and HKU1 in nasopharyngeal and/or oropharnygeal swam samples. Test results may serve as a reference for clinical evaluation of coronavirus 229E, OC43, NL62, and HKU1.
Based on high-efficiency enzymatic processing technology, sample processing and purification are simultaneously completed in one tube to release and stabilize the pathogen nucleic acid.
The test uses specific gene sequences as PCR targets. Human genomic sequence is used as internal quality control.
Only one step for nucleic acid processing, reducing operations to direct PCR sample processing and amplification. Turnaround time is less than 35 minutes.